Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-01-30Clinical Trial Update: Evaluating Efficacy and Tolerability of Anticancer Drug Therapies for the Treatment of Gynecologic and Breast Cancers
This clinical trial update shows recruitment for evaluating efficacy and tolerability of anticancer drug therapies in breast and gynecologic…
-
CLINICAL_TRIALS research · 2025-01-30Clinical Trial Update: Personalized Patient Derived Xenograft (pPDX) Modeling to Test Drug Response in Matching Host
Clinical trial update describing the use of personalized patient-derived xenograft models to test drug response in matching hosts. Recruitme…
-
CLINICAL_TRIALS other · 2025-01-30Clinical Trial Update: [68Ga]Ga-FAPI-46 PET/CT in Ovarian Cancer [Phase 2]
This is an ongoing Phase 2 clinical trial evaluating [68Ga]Ga-FAPI-46 PET/CT in ovarian cancer, currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-01-29Clinical Trial Update: The Impact of the Inflammation Index on Predicting Postoperative Complications in Ovarian Cancer
A completed clinical trial evaluating whether the inflammation index can predict postoperative complications in ovarian cancer patients. The…
-
CLINICAL_TRIALS research · 2025-01-29Clinical Trial Update: Durvalumab Treatment in Combination With Chemotherapy and Bevacizumab, Followed by Maintenance Durvalumab, Bevacizumab and Olaparib Treatment in Advanced Ovarian Cancer Patients [Phase 3]
Phase 3 trial update evaluating durvalumab in combination with chemotherapy and bevacizumab, followed by maintenance durvalumab, bevacizumab…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-01-29Clinical Trial Update: Dysregulation of Whole-body Metabolism in Ovarian Cancer: A Longitudinal Study
A longitudinal study investigating dysregulation of whole-body metabolism in ovarian cancer is currently recruiting. The study is sponsored …
-
CLINICAL_TRIALS research · 2025-01-29Clinical Trial Update: A Study of Avutometinib (VS-6766) v. Avutometinib (VS-6766) + Defactinib in Recurrent Low-Grade Serous Ovarian Cancer With and Without a KRAS Mutation [Phase 2]
Phase 2 study evaluating Avutometinib alone versus combination with Defactinib in recurrent low-grade serous ovarian cancer, including KRAS-…
-
CLINICAL_TRIALS trial_result · 2025-01-29Clinical Trial Update: Abdominopelvic Cancer Prehabilitation [NA]
This clinical trial update reports completion of an abdominopelvic cancer prehabilitation study sponsored by Universitat Jaume I, involving …
-
CLINICAL_TRIALS trial_result · 2025-01-28Clinical Trial Update: Study of a Rapid Triadic Communication Intention Elicitation Intervention to Improve Supportive Oncology Care Delivery [NA]
A completed clinical trial evaluating a rapid triadic communication intention elicitation intervention to improve supportive oncology care d…
-
CLINICAL_TRIALS research · 2025-01-27Clinical Trial Update: A Study of B013 in Combination With Paclitaxel in Patients With Platinum-resistant Recurrent Ovarian Cancer. [Phase 2]
Phase 2 clinical trial of B013 in combination with Paclitaxel for platinum-resistant recurrent ovarian cancer is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-01-24Clinical Trial Update: MicroFluO: FLUorescence-guided Surgery for Ovarian Cancer [NA]
The clinical trial MicroFluO evaluating fluorescence-guided surgery for ovarian cancer has completed.
-
CLINICAL_TRIALS trial_result · 2025-01-23Clinical Trial Update: Pilot Study of Rosuvastatin and Enoxaparin Thromboprophylaxis Following Ovarian Cancer Surgery (O-STAT Study) [Phase 2]
Phase 2 pilot trial evaluating rosuvastatin plus enoxaparin for thromboprophylaxis after ovarian cancer surgery has completed.
-
CLINICAL_TRIALS trial_result · 2025-01-23Clinical Trial Update: Talazoparib in Combination With Belinostat for Metastatic Breast Cancer, Metastatic Castration Resistant Prostate Cancer, and Metastatic Ovarian Cancer [Phase 1]
A Phase 1 trial from the University of Michigan evaluates talazoparib in combination with belinostat in metastatic breast cancer, metastatic…
-
CLINICAL_TRIALS trial_result · 2025-01-23Clinical Trial Update: Validation Study on the Removal of EpCAM-positive Tumour Cells From Blood Collected During Tumour Surgery Using Catumaxomab/Catuvab Device [NA]
A completed validation trial evaluated removal of EpCAM-positive tumor cells from blood collected during tumor surgery using the Catumaxomab…
-
CLINICAL_TRIALS research · 2025-01-23Clinical Trial Update: Evaluation of Salivary RNA in Subjects Scheduled for Surgery for a Gynecologic Pathology
A clinical trial evaluating salivary RNA in subjects scheduled for gynecologic pathology surgery is currently recruiting.
-
CLINICAL_TRIALS research · 2025-01-20Clinical Trial Update: Genetic Landscape in Women with Metastatic Ovarian Cancer Before and During Treatment with PARP Inhibitors [NA]
A clinical trial update examining the genetic landscape of women with metastatic ovarian cancer before and during PARP inhibitor therapy.
-
CLINICAL_TRIALS trial_result · 2025-01-17Clinical Trial Update: A Study of ELI-002 in Subjects With KRAS Mutated Pancreatic Ductal Adenocarcinoma (PDAC) and Other Solid Tumors [Phase 1]
Phase 1 study of ELI-002 in KRAS-mutated pancreatic ductal adenocarcinoma and other KRAS-driven solid tumors has completed enrollment, with …
-
CLINICAL_TRIALS trial_result · 2025-01-17Clinical Trial Update: Newton Study (NEW Dosing MainTenance Therapy Ovarian CaNcer) [Phase 2]
A Phase 2 trial called Newton (NEW Dosing Maintenance Therapy Ovarian Cancer) sponsored by the Mario Negri Institute has been terminated. Th…
-
CLINICAL_TRIALS trial_result · 2025-01-17Clinical Trial Update: COM701 (an Inhibitor of PVRIG) in Subjects With Advanced Solid Tumors. [Phase 1]
Phase 1 clinical trial update for COM701, a PVRIG inhibitor, in adults with advanced solid tumors; the study has completed.
-
CLINICAL_TRIALS other · 2025-01-16Clinical Trial Update: Ovarian Cancer Hemoscope Trial
This is a clinical trial update for the Ovarian Cancer Hemoscope trial. The study is currently ACTIVE_NOT_RECRUITING and is sponsored by the…
-
CLINICAL_TRIALS research · 2025-01-15Clinical Trial Update: Impact of Different BRCA1/2 Gene Variants on Response to Therapy and Prognosis of Ovarian Cancer
A clinical trial evaluating how BRCA1/2 gene variants affect treatment response and prognosis in ovarian cancer, currently recruiting.
-
CLINICAL_TRIALS research · 2025-01-15Clinical Trial Update: Reproductive Health Outcomes in Young Patients With Ovarian Cancer After Surgical Treatment: A Retrospective Study
This clinical trial update describes a planned retrospective study evaluating reproductive health outcomes in young ovarian cancer patients …
-
CLINICAL_TRIALS trial_result · 2025-01-15Clinical Trial Update: KORE-INNOVATION: a Prospective, Multi-site Clinical Trial to Implement and Analyse the Effects of an Innovative Perioperative Care Pathway to Reduce Complications for Patients with Ovarian Cancer [NA]
A completed multi-site trial evaluating a perioperative care pathway to reduce complications in patients with ovarian cancer and related gyn…
-
CLINICAL_TRIALS withdrawal · 2025-01-15Clinical Trial Update: A Study of ASP1893 in Adults With Advanced CLDN6-positive Solid Tumors [Phase 1]
A Phase 1 trial evaluating ASP1893 in adults with CLDN6-positive solid tumors has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2025-01-10Clinical Trial Update: Best Approach in Recurrent-Ovarian-Cancer-with Cediranib-Olaparib [Phase 2]
Phase 2 trial evaluating the combination of cediranib and olaparib for recurrent ovarian cancer has completed with results posted.